GB1461188A - Live influenza virus vaccines and preparation thereof - Google Patents
Live influenza virus vaccines and preparation thereofInfo
- Publication number
- GB1461188A GB1461188A GB4184974A GB4184974A GB1461188A GB 1461188 A GB1461188 A GB 1461188A GB 4184974 A GB4184974 A GB 4184974A GB 4184974 A GB4184974 A GB 4184974A GB 1461188 A GB1461188 A GB 1461188A
- Authority
- GB
- United Kingdom
- Prior art keywords
- strain
- influenza virus
- serum
- recombinant
- sept
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000712461 unidentified influenza virus Species 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 210000002966 serum Anatomy 0.000 abstract 5
- 238000010790 dilution Methods 0.000 abstract 3
- 239000012895 dilution Substances 0.000 abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 238000007865 diluting Methods 0.000 abstract 1
- 235000013601 eggs Nutrition 0.000 abstract 1
- 229960003971 influenza vaccine Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000007923 nasal drop Substances 0.000 abstract 1
- 229940100662 nasal drops Drugs 0.000 abstract 1
- 239000007922 nasal spray Substances 0.000 abstract 1
- 229940097496 nasal spray Drugs 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/401,335 US3953592A (en) | 1973-09-27 | 1973-09-27 | Live influenza virus vaccines and preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1461188A true GB1461188A (en) | 1977-01-13 |
Family
ID=23587327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4184974A Expired GB1461188A (en) | 1973-09-27 | 1974-09-26 | Live influenza virus vaccines and preparation thereof |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US3953592A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS5058223A (cg-RX-API-DMAC10.html) |
| AT (1) | AT331978B (cg-RX-API-DMAC10.html) |
| BE (1) | BE819865A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1030450A (cg-RX-API-DMAC10.html) |
| CH (1) | CH595447A5 (cg-RX-API-DMAC10.html) |
| CS (1) | CS203080B2 (cg-RX-API-DMAC10.html) |
| DD (1) | DD114966A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2445819A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK508274A (cg-RX-API-DMAC10.html) |
| ES (1) | ES430415A1 (cg-RX-API-DMAC10.html) |
| FI (1) | FI278774A7 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2245376B1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1461188A (cg-RX-API-DMAC10.html) |
| HU (1) | HU169383B (cg-RX-API-DMAC10.html) |
| IE (1) | IE40180B1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL45589A (cg-RX-API-DMAC10.html) |
| LU (1) | LU70998A1 (cg-RX-API-DMAC10.html) |
| NL (1) | NL7411746A (cg-RX-API-DMAC10.html) |
| NO (1) | NO743433L (cg-RX-API-DMAC10.html) |
| SE (1) | SE429405B (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA745571B (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0122036A1 (en) * | 1983-03-09 | 1984-10-17 | Teijin Limited | Powdery pharmaceutical composition for nasal administration |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6042209B2 (ja) * | 1974-05-31 | 1985-09-20 | 北里研究所（社団法人） | インフルエンザウイルスの新鮮分離株を発育鶏卵へ短期間で順化させる方法 |
| US4318903A (en) * | 1978-07-12 | 1982-03-09 | Smithkline-Rit | Live influenza virus vaccine and the preparation thereof |
| US4278662A (en) * | 1979-10-16 | 1981-07-14 | Smith Kline - Rit | Attenuated influenza type A virus vaccine |
| US4783411A (en) * | 1984-10-22 | 1988-11-08 | Janis Gabliks | Influenza-A virus vaccine from fish cell cultures |
| NZ224422A (en) * | 1987-05-05 | 1990-11-27 | Molecular Eng Ass | Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid |
| US6398774B1 (en) | 1999-09-29 | 2002-06-04 | Heska Corporation | Intranasal delivery system |
| US7678087B2 (en) * | 1999-09-29 | 2010-03-16 | Heska Corporation | Equine intranasal delivery system |
| RU2290205C1 (ru) * | 2005-09-13 | 2006-12-27 | Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунологическим препаратам "МИКРОГЕН" Министерства здравоохранения Российской Федерации | Способ получения живой вакцины для профилактики гриппа |
| KR101793195B1 (ko) | 2009-03-27 | 2017-11-02 | 아카데미아 시니카 | 바이러스에 대한 면역을 위한 방법 및 조성물 |
| TWI537385B (zh) | 2010-11-04 | 2016-06-11 | 中央研究院 | 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法 |
-
1973
- 1973-09-27 US US05/401,335 patent/US3953592A/en not_active Expired - Lifetime
-
1974
- 1974-08-28 CH CH1173374A patent/CH595447A5/xx not_active IP Right Cessation
- 1974-08-29 CA CA208,125A patent/CA1030450A/en not_active Expired
- 1974-08-30 ZA ZA00745571A patent/ZA745571B/xx unknown
- 1974-09-04 NL NL7411746A patent/NL7411746A/xx not_active Application Discontinuation
- 1974-09-04 IL IL45589A patent/IL45589A/en unknown
- 1974-09-13 BE BE148474A patent/BE819865A/xx not_active IP Right Cessation
- 1974-09-13 FR FR7431029A patent/FR2245376B1/fr not_active Expired
- 1974-09-21 JP JP49109440A patent/JPS5058223A/ja active Pending
- 1974-09-24 NO NO743433A patent/NO743433L/no unknown
- 1974-09-24 CS CS746552A patent/CS203080B2/cs unknown
- 1974-09-25 DE DE19742445819 patent/DE2445819A1/de not_active Ceased
- 1974-09-25 LU LU70998A patent/LU70998A1/xx unknown
- 1974-09-25 FI FI2787/74A patent/FI278774A7/fi unknown
- 1974-09-26 ES ES430415A patent/ES430415A1/es not_active Expired
- 1974-09-26 AT AT776074A patent/AT331978B/de active
- 1974-09-26 DD DD181344A patent/DD114966A5/xx unknown
- 1974-09-26 DK DK508274A patent/DK508274A/da unknown
- 1974-09-26 SE SE7412113A patent/SE429405B/sv unknown
- 1974-09-26 HU HURE565A patent/HU169383B/hu unknown
- 1974-09-26 IE IE1994/74A patent/IE40180B1/xx unknown
- 1974-09-26 GB GB4184974A patent/GB1461188A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0122036A1 (en) * | 1983-03-09 | 1984-10-17 | Teijin Limited | Powdery pharmaceutical composition for nasal administration |
Also Published As
| Publication number | Publication date |
|---|---|
| IL45589A (en) | 1977-05-31 |
| IL45589A0 (en) | 1974-11-29 |
| JPS5058223A (cg-RX-API-DMAC10.html) | 1975-05-21 |
| IE40180L (en) | 1975-03-27 |
| FR2245376A1 (cg-RX-API-DMAC10.html) | 1975-04-25 |
| CH595447A5 (cg-RX-API-DMAC10.html) | 1978-02-15 |
| IE40180B1 (en) | 1979-03-28 |
| ATA776074A (de) | 1975-12-15 |
| DD114966A5 (cg-RX-API-DMAC10.html) | 1975-09-05 |
| HU169383B (cg-RX-API-DMAC10.html) | 1976-11-28 |
| ES430415A1 (es) | 1977-02-01 |
| FR2245376B1 (cg-RX-API-DMAC10.html) | 1978-07-28 |
| LU70998A1 (cg-RX-API-DMAC10.html) | 1975-03-06 |
| SE7412113L (cg-RX-API-DMAC10.html) | 1975-04-01 |
| NO743433L (cg-RX-API-DMAC10.html) | 1975-04-28 |
| AT331978B (de) | 1976-09-10 |
| DK508274A (cg-RX-API-DMAC10.html) | 1975-06-02 |
| NL7411746A (nl) | 1975-04-02 |
| CA1030450A (en) | 1978-05-02 |
| BE819865A (fr) | 1975-03-13 |
| SE429405B (sv) | 1983-09-05 |
| DE2445819A1 (de) | 1975-04-10 |
| US3953592A (en) | 1976-04-27 |
| ZA745571B (en) | 1975-09-24 |
| CS203080B2 (en) | 1981-02-27 |
| AU7330674A (en) | 1976-03-18 |
| FI278774A7 (cg-RX-API-DMAC10.html) | 1975-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yan et al. | Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine | |
| US11510976B2 (en) | H7 avian influenza vaccine strain which differentiates infected from vaccinated animals, preparation method therefor, and application | |
| Levy-Koenig et al. | Immunology of Interferons: II. Heterospecific Activities of Human Interferons and Their Neutralization by Antibody | |
| ATE104698T1 (de) | Influenza-impfstoff. | |
| ES430415A1 (es) | Un procedimiento para preparar una vacuna de virus de la gripe atenuado. | |
| Hirst et al. | A new method for concentrating influenza virus from allantoic fluid | |
| GB1430711A (en) | Live bovine and method ofvaccination using them | |
| Ledinko | Production of plaques with influenza viruses | |
| ES432385A1 (es) | Un metodo de obtener una cepa de virus de la gripe. | |
| McCahon et al. | The production of live attenuated influenza A strains by recombination with A/Okuda/57 (H2N2) | |
| Ibrahim et al. | Spray vaccination with an improved F Newcastle disease vaccine. A comparison of efficacy with the B1 and La Sota vaccines | |
| Nakanaga et al. | Differences in antibody production against mouse hepatitis virus (MHV) among mouse strains | |
| Jensen et al. | Serologic comparisons with lines of influenza virus isolated and serially transferred in different experimental hosts | |
| Heydrick et al. | Host influence on the characteristics of Venezuelan equine encephalomyelitis virus | |
| Cole Jr et al. | Formalin-inactivated Venezuelan equine encephalomyelitis (Trinidad strain) vaccine produced in rolling-bottle cultures of chicken embryo cells | |
| Nishikawa et al. | Isolation of influenza type A viruses from imported pet birds | |
| Iwasaki et al. | Communications: Effect of Lymphocytosis-Promoting Factor (LPF) on the Appearance of Antibodies in Mice Infected with Influenza Virus | |
| CH610347A5 (en) | Process for the preparation of a strain of influenza virus and use of this strain for the production of live viral vaccines against influenza | |
| CN111057683A (zh) | 一种鸡胚接种用病毒稀释液及其制备方法和应用 | |
| Olaleye et al. | Growth of Igbo-Ora virus in some tissue cultures | |
| SU1147029A1 (ru) | Способ профилактики гриппа | |
| Tsuyuki et al. | Inhibition of Mumps and Influenza B Virus Multiplication by Synthetic Poly-D-Lysine. | |
| GB876027A (en) | New vaccines and a process for their manufacture | |
| Johansson et al. | Influenza vaccine strain selection: equivalence of two antigenically distinct haemagglutinin variants of 1989 H3N2 influenza A virus in protection of mice | |
| RU2008351C1 (ru) | Штамм вируса гриппа в/14/28, р для получения живой интраназальной гриппозной вакцины для детей |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |